Zeynep Eroglu, MD, medical oncologist, Department of Cutaneous Oncology, Moffitt Cancer Center, assistant professor, Department of Oncologic Sciences, the University of South Florida, Morsani College of Medicine, discusses the utilization of circulating tumor DNA (ctDNA) in patients with melanoma.
Archive | Video Reports
Dr. Eroglu on the Utilization of ctDNA in Melanoma
Posted in Melanoma News, Health Professionals, Video Reports
New Long-term Data ‘Clearly Favor’ Combination Ipilimumab/Nivolumab in Melanoma
Dr Jeffrey Weber discusses long-term follow-up data presented at ASCO 2021.
Posted in Melanoma News, Health Professionals, Video Reports
Dr. Hamid on the Efficacy of TILs Following Immunotherapy in Advanced Melanoma
Omid Hamid, MD, discusses the efficacy of tumor-infiltrating lymphocyte therapy following immunotherapy in advanced melanoma.
Posted in Melanoma News, Health Professionals, Video Reports
Dr. Hamid on the Differences in Evaluation Criteria for TIL Therapy in Melanoma
Omid Hamid, MD, director, Melanoma Program, Cedars-Sinai Medical Center, chief, Translational Research and Immunotherapy, director, Melanoma Therapeutics, Phase I Immuno-Oncology Program, The Angeles Clinic and Research Institute, discusses the differences in evaluation criteria for tumor-infiltrating lymphocytes (TIL) therapy in melanoma.
Posted in Melanoma News, Health Professionals, Video Reports
 |
 |
 |
 |
